Get alerts on new HERO FINCORP LIMITED bonds
Top yield
9.72%
latest traded
Trading now
36
of 71 live
Instruments
71
outstanding
Top rating
AA+
latest
Traded yield by time to maturity
just issuedEach point is a different security, so the line is a shape, not an apples-to-apples curve. Yields are not directly comparable: seniority, security cover and collateral, put and call options, step-ups and covenants all differ line to line. Read each security on its own terms. Indigo diamonds are brand-new primary issuance plotted at issuance yield (not a traded yield), shown for context against the traded curve.
New primary-market issuance, not yet in the registry below. The yield shown is the issuance yield (weighted-average at issue), not a traded yield.
| The weighted-average yield at which this paper was issued in the primary market — not a secondary traded yield. It reflects the issuer's cost of funds on the issue date. | ||||
|---|---|---|---|---|
| Hero FincorpINE957N14KZ5CP | 90d | ₹10 cr | 8.00% | 05 Nov 2026matures 03 Feb 2027 |
| Hero FincorpINE957N14LF5CP | 273d | ₹25 cr | 8.40% | 04 Nov 2026matures 04 Aug 2027 |
| Hero FincorpINE957N14LE8CP | 92d | ₹25 cr | 8.00% | 28 Oct 2026matures 28 Jan 2027 |
| Hero FincorpINE957N14LD0CP | 91d | ₹200 cr | 7.90% | 21 Oct 2026matures 20 Jan 2027 |
71 securities
| The latest agency surveillance grade where one is on record; otherwise the grade at issue. A rating can migrate after issuance, so the two can differ. | ||||
|---|---|---|---|---|
Hero FincorpINE957N07591NCD | AA+ | 7.35% | 07 May 20314.5y left | 9.72% |
Hero FincorpINE957N08110NCD | AA+ | 9.00% | 05 Jan 20347.2y left | 9.20% |
Hero FincorpINE957N08151NCD | AA+ | 9.20% | 27 May 20303.5y left | 9.17% |
Hero FincorpINE957N08227NCD | AA+ | 9.25% | 07 Jul 203711y left | 9.13% |
Hero FincorpINE957N08193NCD | AA+ | 9.10% | 04 Jun 20358.6y left | 9.10% |
Hero FincorpINE957N08201NCD | AA+ | 9.10% | 18 Jan 20369.2y left | 9.00% |
Hero FincorpINE957N08086NCD | AA+ | 8.65% | 16 Jul 20325.7y left | 8.92% |
Hero FincorpINE957N08219NCD | AA+ | 9.10% | 19 Jan 203710y left | 8.90% |
Hero FincorpINE957N08052NCD | AA+ | 8.85% | 05 Feb 20303.2y left | 8.80% |
Hero FincorpINE957N08102NCD | AA+ | 8.65% | 01 Dec 20326.1y left | 8.77% |
Hero FincorpINE957N08078NCD | AA+ | 7.65% | 11 Dec 20304.1y left | 8.67% |
Hero FincorpINE957N08185NCD | AA+ | 9.30% | 31 Dec 20348.1y left | 8.65% |
Hero FincorpINE957N08045NCD | AA+ | 9.81% | 24 Nov 20282.0y left | 8.55% |
Hero FincorpINE957N07823NCD | AA+ | 8.42% | 02 Jun 20277mo left | 8.40% |
Hero FincorpINE957N07898NCD | AA+ | 8.40% | 31 Jul 20281.7y left | 8.39% |
Hero FincorpINE957N07856NCD | AA+ | 7.80% | 02 Jun 20277mo left | 8.35% |
Hero FincorpINE957N07864NCD | AA+ | 8.09% | 16 Mar 20336.3y left | 8.31% |
Hero FincorpINE957N07674NCD | AA+ | 7.60% | 04 May 20276mo left | 8.10% |
Hero FincorpINE957N07849NCD | AA+ | 7.99% | 06 Aug 20279mo left | 7.98% |
Hero FincorpINE957N08037NCD | AA+ | 8.52% | 18 Jun 20277mo left | 7.85% |
Hero FincorpINE957N07815NCD | AA+ | 8.70% | 31 Dec 20271.1y left | 7.75% |
Hero FincorpINE957N07807NCD | AA+ | 8.70% | 31 Dec 20262mo left | 7.58% |
Hero FincorpINE957N14KG5CP | A1+ | — | 11 Aug 20261mo left | 7.57% |
Hero FincorpINE957N14KU6CP | — | — | 15 Dec 20264mo left | 7.44% |
Hero FincorpINE957N14KR2CP | — | — | 01 Dec 20264mo left | 7.41% |
1–25 of 71
Secured: backed by a charge over the issuer's assets. Unmarked lines are unsecured.
Click any security to compare it across platforms against the live exchange-traded yield. A blank yield means no recent trade, not no value.
Keep exploring
Comparisons
Sammaan Capital14 buyable · up to 9.45%
Navi Finserv12 buyable · up to 11.49%
Vivriti Capital12 buyable · up to 11.00%
Kosamattam Finance9 buyable · up to 11.50%
Muthoot Mcred9 buyable · up to 10.70%
Insights
- Rating actions
upgrades & downgrades
- G-Sec yield curve
- Debt market review
- How to play the tenor
Guide · part 2
Capera
Neutrality
Guarantee
Neutrality guarantee
Prices you can't pay to move.
Capera is editorially independent. We may earn from the platforms and institutions we list, but a commercial arrangement never changes the price or yield we show you.
